Pegfilgrastim
DrugBank ID: DB00019
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| severe nonproliferative diabetic retinopathy | 0.9989 | DL |
| diabetic retinopathy | 0.9973 | DL |
| primary release disorder of platelets | 0.9837 | DL |
| diabetic cataract | 0.9825 | DL |
| pseudo-von Willebrand disease | 0.9803 | DL |
| Glanzmann thrombasthenia | 0.9769 | DL |
| drug-induced osteoporosis | 0.9675 | DL |
| senile cataract | 0.9637 | DL |
| cortical cataract | 0.9631 | DL |
| nuclear senile cataract | 0.9631 | DL |
| craniostenosis cataract | 0.9556 | DL |
| diabetes mellitus type 2 associated cataract | 0.9556 | DL |
| immature cataract | 0.9556 | DL |
| mature cataract | 0.9556 | DL |
| tetanic cataract | 0.9556 | DL |
| dermatitis | 0.9357 | DL |
| hemorrhagic disease of newborn | 0.9226 | DL |
| acrodermatitis chronica atrophicans | 0.9193 | DL |
| neonatal dermatomyositis | 0.9192 | DL |
| pityriasis simplex | 0.9139 | DL |
| thrombocytopenia due to immune destruction | 0.9096 | DL |
| hydroa vacciniforme, familial | 0.9080 | DL |
| acne keloid | 0.9034 | DL |
| amyopathic dermatomyositis | 0.9029 | DL |
| hemorrhagic disorder due to a constitutional thrombocytopenia | 0.9027 | DL |
| secondary interstitial lung disease specific to childhood associated with a connective tissue disease | 0.9010 | DL |
| bleeding diathesis due to a collagen receptor defect | 0.8987 | DL |
| Scott syndrome | 0.8884 | DL |
| filariasis | 0.8863 | DL |
| fetal and neonatal alloimmune thrombocytopenia | 0.8655 | DL |
| esotropia | 0.8650 | DL |
| HER2 positive breast carcinoma | 0.8574 | DL |
| non-syndromic esophageal malformation | 0.8567 | DL |
| neonatal thrombocytopenia | 0.8521 | DL |
| autoimmune thrombocytopenic | 0.8394 | DL |
| breast tumor luminal A or B | 0.8346 | DL |
| normal breast-like subtype of breast carcinoma | 0.8333 | DL |
| progesterone-receptor positive breast cancer | 0.8333 | DL |
| platelet-type bleeding disorder | 0.8246 | DL |
| progesterone-receptor negative breast cancer | 0.8207 | DL |
| biotin metabolic disease | 0.7985 | DL |
| Ehlers-Danlos syndrome, fibronectinemic type | 0.7936 | DL |
| pulmonary edema | 0.7857 | DL |
| diabetic macular edema | 0.7837 | DL |
| autosomal thrombocytopenia with normal platelets | 0.7834 | DL |
| microvascular complications of diabetes, susceptibility to | 0.7810 | DL |
| neutropenia, chronic familial | 0.7619 | DL |
| atypical coarctation of aorta | 0.7581 | DL |
| aortic malformation | 0.7495 | DL |
| pregnancy disorder with abortive outcome | 0.7487 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.